Replies to post #100398 on Biotech Values

[ThomasS]

Quiz:
1. M-enoxaparin not Enoxaparin.
2. Also, FDA green light doesn't mean product hits the shelves...Feb 2011 Hatch-Waxman

[floblu14]

Investors are worried that the moment is approaching when someone will crack Copaxone's complexity.

MNTA has already cracked Copaxone's complexity! :-)

[go seek]

Quiz answer Error: "Teva is suing Sandoz over its plans to market generic Copaxone. George says that the trial is due to start in the third quarter of the year."

no date has been set for trial.

[exwannabe]

Re: MNTA quiz. "When the FDA gives the green light, generic versions of Copaxone will hit the US market."

This is not true as the FDA can approve in 2011 while the lawsuit is still ongoing. The drugs COULD (not will) hit the market then.

[oc631]

After releasing Copaxone Teva lost it's place as the number one generic drug company.

[exwannabe]

Re: MNTA quiz

The generic Copaxone submission (Dec 2007) was 3 years ago, not 2.

[oc631]

How about the title of the article


"Teva is too optimistic about generic Copaxone"


It should read "Teva is too pessimistic about generic Copaxone"